House Bill 5357
116th Congress(2019-2020)
Innovation Network and Capital Act of 2019
Introduced
Introduced in House on Dec 6, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5357
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Innovation Network and Capital Act of 2019
This bill establishes and provides funds through FY2025 for a grant program in the National Institutes of Health (NIH) to expand the commercialization of biomedical products. NIH shall award grants or contracts to entities that have received funding from either the Small Business Innovation Research Program or the Small Business Technology Transfer Program of NIH. Awardees must use the funds to support participation in specified NIH programs and activities related to the commercialization stage of research, later stage research and development, technology transfer, and commercialization technical assistance.
December 6, 2019
Sort by most recent
12/09/2019
Referred to the Subcommittee on Health.
12/06/2019
Referred to the House Committee on Energy and Commerce.
12/06/2019
Introduced in House
Public Record
Record Updated
Oct 28, 2022 1:46:03 AM